C&CAUSES & WHAT WE KNOW
Causes & What We Know/November 17, 2026/3 min read

Diabetes Burden Rising Among Young People in China: What the Data Shows

A major analysis of health data from 1990 to 2021 reveals that Type 1 and Type 2 diabetes are affecting more adolescents and young adults in China, with differences by sex and age. Researchers project these trends may continue through 2050.

Research summaryPubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

causesautoimmunitygeneticsrisk

Key takeaways

  • In 2021, Type 1 diabetes affected about 67 per 100,000 young people aged 10-24 in China, while Type 2 diabetes was much more common at about 1,548 per 100,000
  • Males show greater increases in Type 1 diabetes and related kidney disease compared to females in this age group
  • Type 2 diabetes is rising fastest among teens aged 15-19 years
  • Kidney disease linked to both types of diabetes is occurring in this young population and may worsen over time
  • Understanding these age and sex differences could help shape prevention and screening strategies

Understanding the Study

Researchers analyzed 31 years of health data (1990–2021) on diabetes in Chinese youth aged 10–24 to understand how common the disease is, how it has changed, and what may happen in the future. They used information from the Global Burden of Disease Study, one of the most comprehensive health tracking efforts in the world. The analysis looked at Type 1 diabetes, Type 2 diabetes, and kidney disease caused by each type.

What the 2021 Data Reveals

In 2021, Type 1 diabetes was present in about 67 young people per 100,000 in China. Type 2 diabetes was far more prevalent, affecting approximately 1,548 per 100,000. Kidney disease linked to Type 1 diabetes occurred in about 21 per 100,000, while kidney disease from Type 2 diabetes appeared in about 125 per 100,000.

These numbers show that while Type 2 diabetes is much more common in this age group overall, both conditions and their complications are present among Chinese adolescents and young adults.

Sex and Age Differences Matter

The study found important differences between males and females. Males showed increasing rates of both Type 1 diabetes and kidney disease related to Type 1 diabetes over the study period. Females did not show significant changes in these measures.

When looking at age, researchers noticed that Type 2 diabetes increased most noticeably among young people aged 15–19 years, suggesting that the teen years may be a critical period for Type 2 diabetes development.

What May Happen by 2050

Using statistical models, researchers projected trends forward to 2050. Their projections suggest that in males, both the incidence (new cases) and prevalence (total cases) of Type 1 and Type 2 diabetes may continue to rise through the next several decades.

These projections underscore the importance of monitoring diabetes trends in young people and developing strategies tailored to age and sex to prevent or delay disease onset.

What This Means

This research provides a detailed picture of diabetes burden among Chinese youth and shows that the disease is evolving differently depending on age and sex. The findings highlight the need for health strategies that account for these differences—for example, targeted screening or prevention efforts for males or for teenagers aged 15–19. Understanding these patterns helps public health officials and researchers plan better ways to identify and support young people at risk.

Evidence label

Source: Pediatric diabetes. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

From Type1Cure

Read more of our own writing in Stories

More evidence-labeled coverage across the Type1Cure library.